Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts.
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Type I carbohydrate-deficient glycoprotein syndrome (CDGS) patients fail to add entire N-linked oligosaccharide chains to some serum glycoproteins.Here we show that four CDGS fibroblast cell lines have two related glycosylation abnormalities.First, they incorporate 3-10-fold less [ 3 H] mannose into proteins, and, second, the size of the lipid-linked oligosaccharide precursor (LLO) is much smaller than in controls.Addition of exogenous mannose, but not glucose, to these CDGS cells corrects both the lowered [ 3 H]mannose incorporation and the size of LLO.These corrections are not permanent, and the defects immediately reappear when mannose is removed.To explore further the basis of mannose correction, we analyzed the amount of 3 H-labeled LLO intermediates.Except for dolichol-P-mannose, other precursors, including mannose, mannose-6-phosphate, mannose-1-phosphate, and GDP-mannose, all showed a 3-10fold decrease in CDGS cells.Thus, there are no obvious lesions in the intracellular conversion of mannose into LLO, and, once inside the cell, [ 3 H]mannose appeared to be metabolized normally.Initial velocities of [ 3 H] mannose uptake were two-to threefold less in CDGS cells compared with controls, and this slower transport may partially explain the reduced [ 3 H]mannose incorporation in CDGS cells.Since we previously showed that the enzymes converting glucose to mannose-6-phosphate appear to be normal, our results suggest that cells may acquire or generate mannose in other ways.Although we have not identified the primary defect in CDGS, these studies show that intracellular mannose is limited and that some patients might benefit from including mannose in their regular diets.( J. Clin.Invest.1996.97:1478-1487.)Key words: glycosylation • lipidlinked oligosaccharide • glycoprotein • hexose transporter • CDG syndrome Methods Materials.Most of the materials were obtained from Sigma Chemical Co.(St.Louis, MO), except for the following: concanavalin A (Con A)-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ), ␣ -MEM (GIBCO BRL, Baltimore, MD), FBS (Hyclone Laboratories, Logan, UT), Micropak AX-5 HPLC column (Varian Instruments, Walnut Creek, CA), and microspin filters (Lida Manufacturing Corp., Kenosha, WI).Radiolabels.2-[ 3 H]Mannose (15 Ci/mmol), 2-deoxy[1,2-3 H(N)]glucose (40 Ci/mmol), and [ 35 S]methionine (1,217 Ci/mmol) were obtained from American Radiolabeled Chemicals, Inc. (St. Louis, MO).Cell lines.The CDGS and control cell lines were all obtained from Dr. Neil Buist (Department of Pediatrics, Oregon Health Sciences University, Portland, OR).CDGS 1 and 2, our designation, are patients from the same family (samples F27467 and F27468) described in our previous study (13).CDGS cell lines 3 and 4 are patients from another family (samples F20660 and F02661, coded by Dr. N. Buist).All these patients are diagnosed as type I CDGS based on the clinical and biochemical (transferrin pattern) analyses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSEMBLY OF ASPARAGINE-LINKED OLIGOSACCHARIDES
Kornfeld, R., & Kornfeld, S. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003215 · Cited by 4,906
Facilitated diffusion of glucose
Carruthers, A. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.1135 · Cited by 361
Gould, G. W., Thomas, H. M., Jess, T. J., & Bell, G. I. (1991) · Biochemistry · doi:10.1021/bi00235a004 · Cited by 303
Jaeken, J., van Eijk, H. G., van der Heul, C., Corbeel, L., Eeckels, R., & Eggermont, E. (1984) · Clinica Chimica Acta · doi:10.1016/0009-8981(84)90059-7 · Cited by 280 · cited 1×
“All patients show altered isoelectric focusing patterns of multiple serum glycoproteins that result from undersialylation of their N-linked oligosaccharides (3, 4).”
BackgroundEnvironmental Effects on Protein Glycosylation
Goochee, C. F., & Monica, T. (1990) · Nature Biotechnology · doi:10.1038/nbt0590-421 · Cited by 247
Chapman, A., Fujimoto, K., & Kornfeld, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85510-2 · Cited by 233
Assembly of Asparagine-Linked Oligosaccharides
Kornfeld, R. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.54.1.631 · Cited by 215
Jaeken, J., Schachter, H., Carchon, H., De Cock, P., Coddeville, B., & Spik, G. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.71.2.123 · Cited by 193
The role of N-glycosylation of GLUT1 for glucose transport activity.
Asano, T., Katagiri, H., Takata, K., Lin, J. L., Ishihara, H., Inukai, K., Tsukuda, K., Kikuchi, M., Hirano, H., & Yazaki, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54276-9 · Cited by 187
Jaeken, J., Stibler, H., & Hagberg, B. A. (1991) · PubMed · Cited by 187
Cited by
Items 101–160 of 160
Martin, A., Rambal, C., Berger, V., Périer, S., & Louisot, P. (1998) · Biochimie · doi:10.1016/s0300-9084(98)80059-x · Cited by 20
Congenital disorders of glycosylation: Have you encountered them?
Westphal, V., Srikrishna, G., & Freeze, H. H. (2000) · Genetics in Medicine · doi:10.1097/00125817-200011000-00005 · Cited by 19
Self-citationRevisiting the immunopathology of congenital disorders of glycosylation: an updated review
Pascoal, C., Francisco, R., Mexia, P., Pereira, B. L., Granjo, P., Coelho, H., Barbosa, M., Ferreira, V. D. R., & Videira, P. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1350101 · Cited by 16
Chinese hamster ovary cells with reduced hexokinase activity maintain normal GDP-mannose levels
O'Rear, J. L., Scocca, J. R., Walker, B. K., Kaiden, A., & Krag, S. S. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990101)72:1<56::aid-jcb7>3.0.co;2-h · Cited by 15
Les anomalies congénitales de glycosylation des N-glycosylprotéines
Dupré, T., Lavieu, G., Moore, S. E. H., & Séta, N. (2004) · médecine/sciences · doi:10.1051/medsci/2004203331 · Cited by 14
Congenital disorders of glycosylation
Ivanov, D. O., Новикова, В. П., & Похлебкина, А. А. (2018) · Pediatrician (St Petersburg) · doi:10.17816/ped935-15 · Cited by 14
Syndrome d'hypoglycosylation des glycoprotéines sériques
de Lonlay, P., Cormier‐Daire, V., Vuillaumier‐Barrot, S., Cuer, M., Durand, G., Münnich, A., Saudubray, J., & Séta, N. (2000) · Archives de Pédiatrie · doi:10.1016/s0929-693x(00)88089-6 · Cited by 14
Tahata, S., Weckwerth, J. A., Ligezka, A. N., He, M., Lee, H. E., Heimbach, J. K., Ibrahim, S. H., Kozicz, T., Furuya, K. N., & Morava, É. (2023) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2023.107559 · Cited by 13
Clinical significance of plasma mannose concentrations in healthy and diabetic dogs
Mori, A., Sato, T., Lee, P., Furuuchi, M., Tazaki, H., Katayama, K., Mizutani, H., Sako, T., & Arai, T. (2008) · Veterinary Research Communications · doi:10.1007/s11259-008-9190-3 · Cited by 13
Yamada, N., Kato‐Kogoe, N., Yamanegi, K., Nishiura, H., Fujihara, Y., Fukunishi, S., Okamura, H., Terada, N., & Nakasho, K. (2018) · Anticancer Research · doi:10.21873/anticanres.12358 · Cited by 13
Congenital disorders of glycosylation type Ia and Ib. Genetic, biochemical and clinical studies.
Kjærgaard, S. (2004) · PubMed · Cited by 12
The congenital disorders of glycosylation: A multifaceted group of syndromes
Eklund, E. A., & Freeze, H. H. (2006) · Neurotherapeutics · doi:10.1007/bf03207055 · Cited by 11
Self-citationDefective Glycosyltransferases are Not Good for Your Health
Schachter, H., Tan, J., Sarkar, M., Betty, Y. I. P., Chen, S., Dunn, J., & Jaeken, J. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5383-0_2 · Cited by 9
Carbohydrate-deficient glycoprotein syndrome: Hidden treasures
Gahl, W. A. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90069-x · Cited by 9
Mannose supplementation in PMM2-CDG
Taday, R., Park, J. H., Grüneberg, M., Chesne, I. D., Reunert, J., & Marquardt, T. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01988-x · Cited by 8
Congenital Disorders of Glycosylation: A Review
Albahri, Z. (2015) · Asian Journal of Psychiatry · doi:10.11648/j.ajp.20150102.11 · Cited by 6
31P‐MRS of healthy human brain: Measurement of guanosine diphosphate mannose at 7 T
Ren, J., & Sherry, A. D. (2021) · NMR in Biomedicine · doi:10.1002/nbm.4576 · Cited by 6
Dupré, T., Ogier‐Denis, É., Moore, S. E. H., Cormier‐Daire, V., Dehoux, M., Durand, G., Séta, N., & Codogno, P. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00009-5 · Cited by 6
Inherited Metabolic Disorders Associated with Extrapyramidal Symptoms
Singer, H. S., Mink, J. W., Gilbert, D. L., & Jankovic, J. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7506-9852-8.00015-1 · Cited by 5
Congenital Disorders of Glycosylation
Sosicka, P., Ng, B. G., & Freeze, H. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00013-4 · Cited by 5
Self-citationGlycosylation: General Overview
Jaeken, J., & Carchon, H. A. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.01501-1 · Cited by 5
Insel, P. A., Kornfeld, S., Majerus, P. W., Marks, A. R., Marks, P. A., Relman, A. S., Scharschmidt, B. F., Stossel, T. P., Varki, A. P., Weiss, S. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423321 · Cited by 4
Congenital Defects of Glycosylation: Disorders of N-Glycan Synthesis
Jaeken, J. (2000) · Springer eBooks · doi:10.1007/978-3-662-04285-4_38 · Cited by 4
Beneficial effects of Glc-1,6-P2 modulation on mutant phosphomannomutase-2
Monticelli, M., Paris, D., Monti, M. C., Morretta, E., Pakanová, Z., Nemčovič, M., Kodríková, R., Cubellis, M. V., & Andreotti, G. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119948 · Cited by 3
Introduction to Human Glycosylation Disorders
Freeze, H. H., & Eklund, E. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373600-0.00017-2 · Cited by 3
Self-citationCarbohydrate-deficient glycoprotein syndromes.
Kościelak, J. (1999) · Acta Biochimica Polonica · doi:10.18388/abp.1999_4145 · Cited by 3
Séta, N., Dupré, T., Cormier‐Daire, V., de Lonlay, P., Moore, S. E. H., Durand, G., & Codogno, P. (1999) · médecine/sciences · doi:10.4267/10608/1246 · Cited by 3
Vajro, P., & Mandato, C. (2018) · MDPI eBooks · doi:10.3390/books978-3-03842-924-1 · Cited by 2
Congenital Disorders of Glycosylation
Jaeken, J. (2006) · Springer eBooks · doi:10.1007/978-3-540-28785-8_41 · Cited by 1
Core Issues: Building The Groundwork for N-Linked Sugars
Bill, R. M., Revers, L., & Wilson, I. B. H. (1998) · Springer eBooks · doi:10.1007/978-1-4615-4939-0_4
Phosphomannomutases (PMM Genes)
Matthijs, G., & SCHAFTINGEN, E. V. (2002) · Wiley eBooks · doi:10.1002/0471203076.emm0943
Lübke, T. (2001) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-69
Desarrollo de terapias específicas de mutación en enfermedades metabólicas hereditarias
Checa, P. Y. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Lavieu, G., Frénoy, J., Codogno, P., & Botti, J. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000169962.02462.c0
Abstracts from the Fourth Symposium on Probing Disorders of the White Matter
Moser, H. W. (1999) · Journal of Molecular Neuroscience · doi:10.1385/jmn:12:3:165
Congenital Disorders of Glycosylation and Their Effects on the Liver
Eklund, E. A., & Freeze, H. H. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-524-8_12
Self-citationLes anomalies congénitales des-glycosylprotéines
Dupré, T., Séta, N., Lavieu, G., Moore, S. E. H., Inserm, U., & Vaillant, P. (2004)
Missing N-Glycans on Some Proteins? What's the Problem?
Freeze, H. H. (1997) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.9.239
Self-citationВродени дефекти на гликозилиране
Станчева-Иванова, М. (2016) · Редки болести и лекарства сираци · doi:10.36865/2016.v7i2.52
Pascreau, T. (2019) · theses.fr (ABES) · doi:10.70675/4f5d30f5z6281z4c68za0d6z50e6b1cb256e
Bongiorno, A., & GENNARO, G. D. (1958) · PubMed
Congenital Disorder of Glycosylation (CDG) - Ih
Thiel, C. (2003) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-597
Golden, A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734615740.793556857
Matthijs, G., & SCHAFTINGEN, E. V. (2002) · Springer eBooks · doi:10.1007/978-4-431-67877-9_84
Additional file 3 of Congenital disorders of glycosylation: narration of a story through its patents
Monticelli, M., D’Onofrio, T., Jaeken, J., Morava, É., Andreotti, G., & Cubellis, M. V. (2023) · Figshare · doi:10.6084/m9.figshare.24054321
Additional file 5 of Congenital disorders of glycosylation: narration of a story through its patents
Monticelli, M., D’Onofrio, T., Jaeken, J., Morava, É., Andreotti, G., & Cubellis, M. V. (2023) · Figshare · doi:10.6084/m9.figshare.24054330
Additional file 2 of Congenital disorders of glycosylation: narration of a story through its patents
Monticelli, M., D’Onofrio, T., Jaeken, J., Morava, É., Andreotti, G., & Cubellis, M. V. (2023) · Figshare · doi:10.6084/m9.figshare.24054318
Witters, P., Edmondson, A. C., Lam, C. T., Johnsen, C., Patterson, M. C., Raymond, K., He, M., Freeze, H. H., & Morava, É. (2021) · Figshare · doi:10.6084/m9.figshare.14121539
Self-citationAdditional file 1 of Congenital disorders of glycosylation: narration of a story through its patents
Monticelli, M., D’Onofrio, T., Jaeken, J., Morava, É., Andreotti, G., & Cubellis, M. V. (2023) · Figshare · doi:10.6084/m9.figshare.24054312
Additional file 4 of Congenital disorders of glycosylation: narration of a story through its patents
Monticelli, M., D’Onofrio, T., Jaeken, J., Morava, É., Andreotti, G., & Cubellis, M. V. (2023) · Figshare · doi:10.6084/m9.figshare.24054324
Rindermann, J. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1655
Additional file 1 of Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG)
Taday, R., Grüneberg, M., Chesne, I. D., Reunert, J., & Marquardt, T. (2020) · Figshare · doi:10.6084/m9.figshare.12992107
Characterization and therapy of congenital disorders of glycosylation
Häuptle, M. A. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-25761
Gücüm, S. (2021) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00030086
Congenital disorder of glycosylation typ Ia
Hüer, C. (. (2005) · URN:NBN Resolver for Germany & Switzerland (German National Library)
Tratamiento nutricional en niños con defecto congénito de glicosilación
De León Cabrera, R., & Moreno Loshuertos, R. (2017) · Zaguan (Universidad de Zaragoza)
Congenital disorders of glycosylation type IA
Станчева/Stancheva., М. /. (2009) · Bulgarian Portal for Open Science
Biosynthèse et dégradation des N-glycoprotéines : un métabolisme intimement lié à la Man2C1
Bernon, C. (2010) · theses.fr (ABES) · doi:10.70675/d665d42ez6918z4d0dz85c9z3a4636198d9c
Zhang, Y., Ding, J., Wang, X., Meng, R., Jia, S., Wu, X., Zhu, J., Peng, X., & Weiliang, S. H. E. N. (2026) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2026.120275
Metadata
- Authors
- Panneerselvam, K., & Freeze, H. H.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Oregon Health & Science University (US)
- ORCID
- Freeze, H H
- Venue
- Journal of Clinical Investigation
- Published
- 1996-03-15
- Volume
- 97
- Issue
- 6
- Pages
- 1478-1487
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507208
- OpenAlex
- W2015514724
- Cited by
- 146
- References
- 57
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 9 · 2017: 2 · 2016: 5 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 5
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (R01 49096)
- National Institute of General Medical Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- congenital disorders of glycosylation, N-glycosylation, mannose, lipid-linked oligosaccharides, mannose-6-phosphate, mannose-1-phosphate, GDP-mannose, hexose transporters, fibroblasts, glycoprotein synthesis, congenital disorders
- MeSH terms
- Cell Line, Fibroblasts, Glycosylation, Humans, Mannose, Oligosaccharides, Congenital Disorders of Glycosylation, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.